NA | OXYGEN [Praxair Mexico, S. de R.L. de C.V] | BioPortfolio

12:33 EST 27th January 2019 | BioPortfolio

Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

PRAXAIR                               Track No: 012

Haciendo nuestro planeta mds productive

Certificate of Analysis (COA)


700 Via Matamoros drive, Garza Cantu

San Nicolas de los Garza, Nuevo Leon,

64550 Mexico

Oxygen USP NDA:                            589381                  Customer Name:              Praxair Inc – Harlingen Tx

FDA Establishment Identifier:     301258051           Praxair Number:               6010667

DUNS Number:                                 812953909


Batch Number:

OXMIS IC0917 MIS LOX 01 1026

Order:                   Lot Number:                                                                      Shipping Container:

98579309             OX MIS 101017 PRXM481 0053                                   481

Expiration date:                2018 01 09

This product described in this document meets the requirements of the United States Pharmacopeia 40 edition, 2017, and specifications of Praxair Mexico, S. de R.L. de C.V.

Component                        Specification                     Analytical Result Analytical Method Analyzer Used

Assay                                    NLT 99.5% by volume     99.89%v/v                           Paramagnetic                    Servomex 4100

Identification                     Positive                                Positive                                Paramagnetic                    Servomex 4100

Tester’s Signature:           XXXXXXXXXXXXXXXXXXXXXX


                                                Quality Assurance Reviewer

Notes: 1.  Liquid oxygen produced by the air liquefaction process.

2.  Product is identified as Oxygen by way of oxygen specific paramagnetic analyzers

                3.  Product is identified as oxygen through process validation, dedicated piping and product specific CGA fittings.

Date/Time:         2017 10 10                          01:26                                                     OO/R-02-080/1-10


Praxair Mexico, S. de R.L. de C.V

Active Ingredients


Clinical Trials [1471 Associated Clinical Trials listed on BioPortfolio]

Maternal Oxygen Administration for Fetal Distress II

Supplementary oxygen is routinely administered to patients, even those with adequate oxygen saturations, in the belief that it increases oxygen delivery. However, oxygen delivery depends n...

Intelligent Oxygen Therapy During Sleep

Long-term oxygen therapy improves survival in patients with severe hypoxia. However, some patients despite this oxygen, experience episodes of low oxygen levels (intermittent hypoxia) espe...

Effect of High Levels of Oxygen and Smoking on the Lungs in Human Volunteers

Patients with lung disease experiencing difficulty breathing can be treated with oxygen therapy. This involves the delivery of "extra" oxygen by a face-mask or through small tubes placed ...

Portable Oxygen Concentrator Improvements to Physical Activity, Oxygen Usage, and Quality of Life in Chronic Obstructive Pulmonary Disease Patients Using Long-term Oxygen Therapy (POC-STEP)

To evaluate changes in activity based on the use of portable oxygen concentrators combined with standard of care (SOC) long- term oxygen therapy versus SOC long-term oxygen therapy alone a...

Evaluation of Oxygen Delivery Through Nasal Cannula in Volunteers

This study will evaluate patient comfort and oxygen delivery efficiency when providing supplemental oxygen through a nasal cannula to volunteers using an instrumented oxygen delivery syste...

PubMed Articles [3594 Associated PubMed Articles listed on BioPortfolio]

Enzymatic glucose/oxygen biofuel cells: Use of oxygen-rich cathodes for operation under severe oxygen-deficit conditions.

A glucose/oxygen biofuel cell (BFC) that can operate continuously under oxygen-free conditions is described. The oxygen-deficit limitations of metabolite/oxygen enzymatic BFCs have been addressed by u...

Oxygen Reserve Index: Validation of a New Variable.

Pulse oximetry-derived oxygen saturation is typically >97% in normoxia and hyperoxia, limiting its clinical use. The new Oxygen Reserve Index (ORi), a relative indicator of the partial pressure of oxy...

The effect of oxygen concentration on arterial blood partial pressure of oxygen in dogs under general anesthesia.

Oxygen is used for medical treatment and general anesthesia. However, high concentrations of oxygen can have toxic effects on cells. In veterinary medicine, 100% oxygen is usually used during general ...

Oxygen toxicity in acute care settings.

Oxygen therapy is widespread in acute care settings as adequate oxygen supplementation is essential in case of hypoxemia. Excessive oxygen supplementation has several unrecognized deleterious effects....

Development and validation of a questionnaire to assess the doctors and nurses knowledge of acute oxygen therapy.

Prescription and administration of oxygen in emergencies by healthcare providers are reported to be inappropriate in most settings. There is a huge gap in the knowledge of health care providers on var...

Quick Search


Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity.  This can be a drug or biochemical substance or a cell in an organism or organic sample. ...

Drugs and Medication Quicklinks

Searches Linking to this Drug Record